PLC β2 Inhibitors
PLC β2 inhibitors comprise a diverse array of compounds designed to specifically modulate the activity of phospholipase C (PLC) β2, shedding light on its intricate roles in cellular signaling networks. These inhibitors can be broadly categorized into direct and indirect modulators, offering unique insights into the regulatory mechanisms governing PLC β2 function. Direct inhibitors such as U73122, U73111, and ONO-RS-082 target the catalytic activity of PLC β2, disrupting the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) and impairing downstream signaling events. These inhibitors provide precise tools for studying the isoform-specific functions of PLC β2 in diverse cellular processes, unraveling the intricacies of its signaling cascades.
Indirect modulators like Edelfosine, D609, and Neomycin influence PLC β2 through alternative mechanisms. Edelfosine, a membrane-perturbing agent, indirectly modulates PLC β2 by affecting membrane structure and lipid composition. D609 and its hydrochloride salt form (D609 hydrochloride), phosphatidylcholine-specific phospholipase C (PC-PLC) inhibitors, disrupt lipid metabolism, indirectly altering PLC β2 activity. Neomycin, an aminoglycoside antibiotic, interacts with PIP2, indirectly influencing PLC β2 activity. These indirect modulators offer diverse approaches for dissecting the complex regulatory networks governing PLC β2-mediated cellular responses. Additionally, compounds like Diallyl Trisulfide, RHC-80267, Oleoyl Ethanolamide, M-3M3FBS, and O-1602 provide alternative avenues for studying PLC β2. Diallyl Trisulfide modulates redox signaling pathways, RHC-80267 affects diacylglycerol levels, Oleoyl Ethanolamide interacts with cannabinoid receptors, and M-3M3FBS and O-1602 serve as activators with potential application in experimental manipulation. In conclusion, this chemical class of PLC β2 inhibitors offers a comprehensive toolkit for researchers seeking to unravel the complex roles of PLC β2 in cellular signaling. The diversity in mechanisms, ranging from direct catalytic inhibition to indirect modulation through membrane perturbation and lipid metabolism, provides a nuanced understanding of the regulatory networks governing PLC β2 function in diverse cellular contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
ET-18-OCH3 | 77286-66-9 | sc-201021 sc-201021A sc-201021B sc-201021C sc-201021F | 5 mg 25 mg 50 mg 100 mg 1 g | $111.00 $436.00 $843.00 $1576.00 $3756.00 | 6 | |
Edelfosine, a membrane-perturbing agent, indirectly modulates PLC β2 by affecting membrane structure and lipid composition. Alterations in membrane properties influence the localization and activity of PLC β2, leading to downstream changes in signaling cascades. | ||||||
D609 | 83373-60-8 | sc-201403 sc-201403A | 5 mg 25 mg | $189.00 $575.00 | 7 | |
D609, a phosphatidylcholine-specific phospholipase C (PC-PLC) inhibitor, indirectly influences PLC β2 by disrupting the hydrolysis of phosphatidylcholine. This interference in lipid metabolism indirectly modulates PLC β2 activity, showcasing D609's potential as an indirect inhibitor. By targeting upstream lipid signaling pathways, D609 offers insights into the intricate interplay between lipid metabolism and PLC β2-mediated cellular responses. | ||||||
Diallyl trisulfide | 2050-87-5 | sc-205645 sc-205645A | 100 mg 500 mg | $160.00 $405.00 | 3 | |
Diallyl Trisulfide, an organosulfur compound, indirectly influences PLC β2 by modulating redox signaling pathways. Through its impact on cellular redox status, Diallyl Trisulfide indirectly alters PLC β2 activity, showcasing its potential as an indirect modulator. The redox-sensitive nature of PLC β2 makes compounds like Diallyl Trisulfide valuable for investigating the intricate connections between redox signaling and PLC β2-mediated cellular responses. | ||||||
Neomycin sulfate | 1405-10-3 | sc-3573 sc-3573A | 1 g 5 g | $27.00 $35.00 | 20 | |
Neomycin, an aminoglycoside antibiotic, indirectly modulates PLC β2 by interacting with phosphatidylinositol 4,5-bisphosphate (PIP2). Through its binding to PIP2, Neomycin influences the availability of substrate for PLC β2, indirectly impacting its activity. This indirect modulation provides a unique approach to study the intricate interactions between membrane components and PLC β2, shedding light on the regulatory mechanisms governing PLC β2-mediated cellular responses. | ||||||
ONO-RS-082 | 99754-06-0 | sc-201410 sc-201410A | 20 mg 100 mg | $83.00 $230.00 | ||
ONO-RS-082, a selective PLC inhibitor, directly targets PLC β2 by inhibiting its catalytic activity. Through the specific inhibition of PLC β2, ONO-RS-082 disrupts the hydrolysis of PIP2, leading to impaired downstream signaling events. This direct inhibition highlights ONO-RS-082 as a valuable tool for investigating the isoform-specific functions of PLC β2 in diverse cellular processes, providing insights into the precise roles of PLC β2 in signaling networks. | ||||||
Oleylethanolamide | 111-58-0 | sc-201400 sc-201400A | 10 mg 50 mg | $90.00 $194.00 | 1 | |
Oleoyl Ethanolamide, an endocannabinoid-related compound, indirectly influences PLC β2 by interacting with cannabinoid receptors. Through its interaction with these receptors, Oleoyl Ethanolamide modulates downstream signaling pathways that intersect with PLC β2-mediated cascades. | ||||||
m-3M3FBS | 200933-14-8 | sc-202217 sc-202217A | 10 mg 50 mg | $141.00 $630.00 | 10 | |
M-3M3FBS, a potent and selective activator of PLC β2, is included as a tool compound for experimental manipulation. Although its primary function is as an activator, its use in conjunction with inhibitors allows for controlled modulation of PLC β2 activity. | ||||||
O-1602 | 317321-41-8 | sc-202745 sc-202745A | 1 mg 5 mg | $208.00 $416.00 | ||
O-1602, a synthetic cannabinoid receptor agonist, indirectly modulates PLC β2 through cannabinoid receptor activation. By engaging cannabinoid receptors, O-1602 influences downstream signaling pathways that intersect with PLC β2-mediated cascades. This indirect modulation offers a unique avenue for studying the cross-talk between cannabinoid signaling and PLC β2, providing insights into the intricate regulatory mechanisms governing PLC β2-dependent cellular responses. | ||||||